Publikation

Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation.

Wissenschaftlicher Artikel/Review - 29.08.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Wenzl F, Kraler S, Ambler G, Weston C, Herzog S, Räber L, Muller O, Camici G, Roffi M, Rickli H, Fox K, de Belder M, Radovanovic D, Deanfield J, Lüscher T. Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation. Lancet 2022; 400:744-756.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Lancet 2022; 400
Veröffentlichungsdatum
29.08.2022
eISSN (Online)
1474-547X
Seiten
744-756
Kurzbeschreibung/Zielsetzung

The Global Registry of Acute Coronary Events (GRACE) 2.0 score was developed and validated in predominantly male patient populations. We aimed to assess its sex-specific performance in non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and to develop an improved score (GRACE 3.0) that accounts for sex differences in disease characteristics.